Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C
Journal of Neurodegenerative Diseases · 2013
DOI: 10.1155/2013/407903 ↗Abstract
Cerebral elevation of 42-residue amyloid β -peptide (A β 42) triggers neuronal dysfunction in Alzheimer's disease (AD). Even though a number of cholesterol modulating agents have been shown to affect A β generation, the role of cholesterol in the pathogenesis of AD is not clear yet. Recently, we have shown that increased membrane cholesterol levels downregulates phosphatidylinositol 4,5-bisphosphate (PIP 2 ) via activation of phospholipase C (PLC). In this study, we tested whether membrane cholesterol levels may affect the A β 42 production via changing PIP 2 levels. Increasing membrane cholesterol levels decreased PIP 2 and increased secreted A β 42. Supplying PIP 2 , by using a PIP 2 -carrier system, blocked the effect of cholesterol on A β 42. We also found that cholesterol increased the expressions of β 1 and β 3 PLC isoforms (PLC β 1, PLC β 3). Silencing the expression of PLC β 1 prevented the effects of cholesterol on PIP 2 levels as well as on A β 42 production, suggesting that increased membrane cholesterol levels increased secreted A β 42 by downregulating PIP 2 via enhancing the expression of PLC β 1. Thus, cholesterol metabolism may be linked to A β 42 levels via PLC β 1 expression and subsequent changes in PIP 2 metabolism.
EUVIMED